$CRDO

Fleming Daniel W. sold $1.9M of CRDO

Fleming Daniel W. (Chief Financial Officer) sold 7,580 shares of Credo Technology Group Holding Ltd (CRDO) at an average of $245.88 ($240.61–$249.61, $1.86M total) across 10 trades on 2026-07-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fleming Daniel W.
Published Jul 13, 2026, 7:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 8:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CRDO
Neutral
medium confidence
Mentioned
$CRDO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRDONeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (date, shares, price range, and total value) disclosed on 2026-07-13.

02

Market read

Insider selling can create short-term sentiment noise, but 10b5-1 structure usually limits interpretive value.

03

What to watch

Traders may over-weight insider sales; without accompanying guidance, earnings, or operational updates, the signal is usually weak.

Relevance 5/10Novelty 5/10Timing: after-hours filing disclosure on 2026-07-13 for a 2026-07-08 sale

Background

The article is an SEC Form 4 insider transaction report for Credo Technology Group Holding Ltd.

Company-level read

Ticker impact

$CRDONeutralMedium confidence
Context

CFO Daniel W. Fleming sold about $1.86M of Credo Technology shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 insider transaction (open-market sale) with a pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

Minimal, as the disclosure is company-specific and does not change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Credo Technology Group Holding Ltd

    Subject of the Form 4 insider transaction disclosure.

  • Daniel W. Fleming

    Chief Financial Officer who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRDOMed

Why is Credo Technology stock rallying today?

Credo Technology (CRDO) shares rose 6.0% to $186.49 after analysts highlighted its optical networking solutions at ECOC 2026. Mizuho maintained an Outperform rating, lowering its target to $245, while Rosenblatt initiated coverage with a Buy and a $235 target. The stock trades 43% below its 52-week high despite 115% revenue growth, with consensus targets implying 61% upside.

$CRDOMed

What's Going On With Credo Technology Stock on Thursday?

Credo Technology (CRDO) shares rose 4% in premarket trading on Thursday. The company launched its 224G-based ZeroFlap optical transceiver family for AI networking, a key step in its roadmap. Credo reported Q1 2027 revenue of $479M, beating estimates, with CEO Bill Brennan highlighting AI infrastructure as a growth driver. Analysts maintain a Buy rating with an average price target of $273.07.

$CRDOMedAI 8/10

Credo vs. Broadcom: Which AI Connectivity Stock Is the Better Pick?

Credo (CRDO) and Broadcom (AVGO) are both benefiting from the AI infrastructure boom. Credo reported Q1 revenues of $479M, up 115% YoY, with strong growth in optical and AEC segments. Broadcom saw Q3 revenues of $29.59B, up 85.5% YoY, with AI semiconductors representing 56% of total revenue. Both companies show strong growth but face risks like customer concentration and execution challenges.